Capio Biosciences vs Caribou Biosciences

Capio Biosciences logo

Capio Biosciences

4 employees · est. 2015 · Madison, United States

VS
Caribou Biosciences logo

Caribou Biosciences

Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases

128 employees · est. 2012 · Berkeley, United States

Caribou Biosciences is the older company (2015 vs 2012); Caribou Biosciences is the larger of the two.

Side-by-Side Comparison

Capio Biosciences Caribou Biosciences
Founded
2015 2012 older
Headquarters
Madison, United States Berkeley, United States
Employees
4 128 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A IPO
Total Funding
$2.90M $588.55M
Funding Rounds
1 8
Services
Not tracked yet Development of genome-edited cell therapies, CRISPR-based technology solutions, Clinical research and trials
Target Customers
Not tracked yet Patients with devastating human diseases, Healthcare providers, Biopharmaceutical stakeholders
Taxonomy
Liquid BiopsyOncology DiagnosticsCirculating Tumor CellsBiomimetic Cell RollingDendrimer-mediated CaptureCTC Capture Sensitivity +9 CRISPR Genome EditingBiopharmaceuticalsCell TherapyAllogeneic CAR-THematologic MalignanciesAutoimmune Diseases +9
Website
capiobiosciences.com cariboubio.com
Capio Biosciences logo

About Capio Biosciences

Capio Biosciences is a US-based biotech startup founded in 2015 by Seungpyo Hong PhD and Andrew Wang MD. The company's vision is to become the world's leading liquid biopsy company, providing valuable clinical information to improve patient outcomes. Capio Biosciences is committed to delivering high...

Caribou Biosciences logo

About Caribou Biosciences

Caribou Biosciences, founded in 2012 and headquartered in the United States, is a clinical-stage biopharmaceutical company at the forefront of developing transformative therapies using advanced CRISPR genome-editing technologies. The company operates in the Biotechnology, Health Care, and Health and...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Capio Biosciences and Caribou Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Capio Biosciences or Caribou Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Capio Biosciences was founded in 2015, based in Madison, United States, with 4 employees. Capio Biosciences is a US-based biotech startup founded in 2015 by Seungpyo Hong PhD and Andrew Wang MD. The company's vision is to become the world's leading liquid biopsy company, providing valuable. Caribou Biosciences was founded in 2012, based in Berkeley, United States, with 128 employees. Caribou Biosciences, founded in 2012 and headquartered in the United States, is a clinical-stage biopharmaceutical company at the forefront of developing transformative therapies using advanced CRISPR.
Capio Biosciences has raised $2.90M and Caribou Biosciences $588.55M. Latest stage: Capio Biosciences Series A, Caribou Biosciences IPO.
Both work in Biotechnology and Health Care.

Compare Capio Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Capio Biosciences on 12 Sep 2024, and Caribou Biosciences on 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes